Tau PET Imaging With 18F-T807(AV1451) in Neurodegenerative Disorders
Latest Information Update: 02 Dec 2021
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Neurodegenerative disorders
- Focus Diagnostic use
- 23 Nov 2021 Planned primary completion date changed from 1 Jun 2024 to 1 Dec 2024.
- 21 Jun 2021 New trial record